Galderma Group Stock
Galderma Group AG
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Switzerland
- CEO
- Flemming Ørnskov
- Employees
- 7,676
- Market cap
- CHF41.1 B
- IPO
- 22/03/2024
Galderma Group AG operates as a dermatology company worldwide within the healthcare sector. The company delivers a science-based portfolio of brands and services for the dermatology market, which includes injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands in…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Galderma Group stock: price history
1D
+2.3%
1W
+6.7%
1M
+14.3%
6M
+12.2%
YTD
+8.6%
1Y
+27.0%
2Y
+121.3%
5Y
–
10Y
–
Next earnings date
Next earnings date
11/03/2027 (in 145 days)
Volatility around earnings
~104% stronger price swings than usual
Ask the agents about Galderma Group
Galderma Group stock metrics
P/E
58.34
P/B
6.06
EV/EBITDA
38.97
RETURN ON EQUITY
5.3%
NET MARGIN
14.2%
DEBT/EQUITY
0.33
DIVIDEND YIELD
0.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
41.3%
FLOAT SHARES
96,248,733
AVG. DAILY VOLUME (30D)
780,402
Dividends
Comparable stocks
Frequently asked questions about Galderma Group stock
What does Galderma Group do?
Galderma Group AG is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Switzerland.
The CEO is Flemming Ørnskov, the company employs around 7,676 people.
The IPO was on 22/03/2024; the stock trades on SIX under the ticker GALD.SW.
When does Galderma Group report next?
The next earnings date is 11/03/2027.
Around past earnings, price swings were roughly 104% stronger than usual.
Does Galderma Group pay a dividend?
Yes. The last dividend was CHF 0.35 per share, ex-date 24/04/2026, paid on 28/04/2026.
The dividend yield is 0.2% (as of 30/06/2026).
Which stocks are comparable to Galderma Group?
Comparable stocks include Sandoz Group, Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Galderma Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Galderma Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.